|
Neuropathology
Citations 131-140 of 161 total displayed.
|
Past content
(since Feb 1998):
|
- Original Contributions
Cerebrospinal Fluid Tau and  -Amyloid 42 Proteins Identify Alzheimer Disease in Subjects With Mild Cognitive Impairment
- M. Riemenschneider; N. Lautenschlager; S. Wagenpfeil; J. Diehl; A. Drzezga; A. Kurz
Arch Neurol 2002; 59: 1729-1734.
[Abstract]
[Full text]
[PDF]
- Original Contributions
The Role of Cerebrospinal Fluid Hypocretin Measurement in the Diagnosis of Narcolepsy and Other Hypersomnias
- Emmanuel Mignot; Gert Jan Lammers; Beth Ripley; Michele Okun; Sonia Nevsimalova; Sebastiaan Overeem; Jitka Vankova; Jed Black; John Harsh; Claudio Bassetti; Harald Schrader; Seiji Nishino
Arch Neurol 2002; 59: 1553-1562.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Spontaneous "Second Wind" and Glucose-Induced Second "Second Wind" in McArdle Disease: Oxidative Mechanisms
- Ronald G. Haller; John Vissing
Arch Neurol 2002; 59: 1395-1402.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Differential Diagnosis of Alzheimer Disease With Cerebrospinal Fluid Levels of Tau Protein Phosphorylated at Threonine 231
- Katharina Buerger; Raymond Zinkowski; Stefan J. Teipel; Tero Tapiola; Hiroyuki Arai; Kaj Blennow; Niels Andreasen; Klaus Hofmann-Kiefer; John DeBernardis; Daniel Kerkman; Cheryl McCulloch; Russell Kohnken; Frank Padberg; Tuula Pirttilä; Marc B. Schapiro; Stanley I. Rapoport; Hans-Jürgen Möller; Peter Davies; Harald Hampel
Arch Neurol 2002; 59: 1267-1272.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Correlation of Regional Proton Magnetic Resonance Spectroscopic Metabolic Changes With Cognitive Deficits in Mild Alzheimer Disease
- Sophie Chantal; Martin Labelle; Rémi W. Bouchard; Claude M. J. Braun; Yvan Boulanger
Arch Neurol 2002; 59: 955-962.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Echogenicity of the Substantia Nigra: Association With Increased Iron Content and Marker for Susceptibility to Nigrostriatal Injury
- Daniela Berg; Wolfgang Roggendorf; Ute Schröder; Rüdiger Klein; Thomas Tatschner; Peter Benz; Oliver Tucha; Michael Preier; Klaus W. Lange; Karlheinz Reiners; Manfred Gerlach; Georg Becker
Arch Neurol 2002; 59: 999-1005.
[Abstract]
[Full text]
[PDF]
- Editorials
Experimental Neurotherapeutics: Leaps and Bounds
- Ira Shoulson
Arch Neurol 2002; 59: 689-691.
[Extract]
[Full text]
[PDF]
- Original Contributions
Lymphocyte Oxidative DNA Damage and Plasma Antioxidants in Alzheimer Disease
- Patrizia Mecocci; M. Cristina Polidori; Antonio Cherubini; Tiziana Ingegni; Paola Mattioli; Marco Catani; Patrizia Rinaldi; Roberta Cecchetti; Wilhelm Stahl; Umberto Senin; M. Flint Beal
Arch Neurol 2002; 59: 794-798.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Regional N-Acetylaspartate Reduction in the Hippocampus Detected With Fast Proton Magnetic Resonance Spectroscopic Imaging in Patients With Alzheimer Disease
- Wolfgang Block; Frank Jessen; Frank Träber; Sebastian Flacke; Christoph Manka; Rolf Lamerichs; Ewald Keller; Reinhard Heun; Hans Schild
Arch Neurol 2002; 59: 828-834.
[Abstract]
[Full text]
[PDF]
- Original Contributions
Oligoclonal Band Number as a Marker for Prognosis in Multiple Sclerosis
- Jagannadha R. Avasarala; Anne H. Cross; John L. Trotter
Arch Neurol 2001; 58: 2044-2045.
[Abstract]
[Full text]
[PDF]
|
|
